Skip to main content

Advertisement

Log in

Prediction and prevention of type I diabetes

  • Views
  • Facts, perspectives and opinions on selected topics
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Thomson G., Robinson W.P., Kuhner M.K., et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 43: 799, 1988.

    PubMed Central  PubMed  CAS  Google Scholar 

  2. Khalil I., Deschamps I., Lepage V., Al-Daccak R., Degos L., Hors J. Dose effect of Cis- and Trans-Encoded HLA-DQalpha/beta heterodimers in IDDM susceptibility. Diabetes 41: 378, 1992.

    Article  PubMed  CAS  Google Scholar 

  3. Pugliese A., Bain S.C., Todd J.A., Awdeh Z.L., Alper C.A., Eisenbarth G.S. INS polymorphisms on chromosome 11 in type I diabetes. Autoimmunity 15 (Suppl): 32, 1993.

    Google Scholar 

  4. Baisch J.M., Week T., Giles R., Hoover M., Stastny P., Capra D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322: 1836, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. Dotta F., Previti M., Tiberti C., Lenti L., Pugliese G., Di Mario U. Identification of the GM2-1 islet ganglioside: Similarities with a major neuronal autoantigen. Diabetes 41: 365A, 1992.

    Google Scholar 

  6. Bonifacio E., Bingley P.J., Shattock M., et al. Quantitative islet cell antibody measurement assists in the prediction of insulin-dependent diabetes. Lancet 335: 147, 1990.

    Article  PubMed  CAS  Google Scholar 

  7. Bonifacio E., Dawkins R.L., Lernmark A. Immunology and diabetes workshops: report of the second international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 30: 273, 1987.

    Article  Google Scholar 

  8. Genovese S., Bonifacio E., McNally J.M., et al. Distinct cytoplasmic islet cell antibodies with different risks for type I (insulin-dependent) diabetes mellitus. Diabetologia 35: 385, 1992.

    Article  PubMed  CAS  Google Scholar 

  9. Gianani R., Pugliese A., Bonner-Weir S., et al. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with Type I Diabetes. Diabetes 41: 347, 1992.

    Article  PubMed  CAS  Google Scholar 

  10. Gianani R., Jackson R., Eisenbarth G.S. Evidence that the autoantigen of restricted ICA is GAD. Diabetes Research and Clinical Practice 14(suppl. 1): S13, 1991.

    Google Scholar 

  11. Richter W., Seissler J., Northemann W., Wolfahrt S., Meinck H., Scherbaum W.A. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome. Diabetes 42: 1642, 1993.

    Article  PubMed  CAS  Google Scholar 

  12. Nayak R.C., Omar M.A.K., Rabizadeh A., Srikanta S., Eisenbarth G.S. “Cytoplasmic” islet cell antibodies: evidence that the target antigen is a sialogycoconjugate. Diabetes 34: 617, 1985.

    Article  PubMed  CAS  Google Scholar 

  13. Spencer K.M., Dean B.M., Tarn A., Lister J., Bottazzo G.F. Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet 1: 764, 1984.

    Article  PubMed  CAS  Google Scholar 

  14. Bingley P.J., Bonifacio E., Shattock M., et al. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 16: 45, 1993.

    Article  PubMed  CAS  Google Scholar 

  15. Palmer J.P., Asplin C.M., Clemons P., et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337, 1983.

    Article  PubMed  CAS  Google Scholar 

  16. McEvoy R., Witt M.E., Ginsberg-Fellner F., Rubinstein P. Anti-insulin antibodies in children with type I diabetes mellitus. Diabetes 35: 634, 1986.

    Article  PubMed  CAS  Google Scholar 

  17. Greenbaum C., Palmer J.P., Kuglin B., Kolb H., and Participating Laboratories. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: Results of the fourth international workshop on the standardization of insulin autoantibody measurement. J. Clin. Endocrinol. Metab. 74: 1040, 1992.

    PubMed  CAS  Google Scholar 

  18. Vardi P., Ziegler A.G., Matthews J.H., et al. Concentration of insulin autoantibodies at onset of Type I diabetes: inverse log-linear correlation with age. Diabetes Care 11: 736, 1988.

    PubMed  CAS  Google Scholar 

  19. Petersen J.S., Russel S., Marshall M.O., et al. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42: 484, 1993.

    Article  PubMed  CAS  Google Scholar 

  20. Erlander M.G., Tillakaratne N.J.K., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases with different responses to pyridoxal phosphate. Neuron 7: 91, 1991.

    Article  PubMed  CAS  Google Scholar 

  21. Reetz A., Solimena M., Matteoli M., Folli F., Takei K., DeCamilli P. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO Journal 10: 1275, 1991.

    PubMed Central  PubMed  CAS  Google Scholar 

  22. Solimena M., Folli F., Aparisi R., Pozza G., DeCamilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in Stiff-Man syndrome. N.Engl.J.Med. 322: 1555, 1990.

    Article  PubMed  CAS  Google Scholar 

  23. Baekkeskov S., Aanstoot H., Christgau S., et al. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151, 1990.

    Article  PubMed  CAS  Google Scholar 

  24. Christie M.R., Vohra G., Champagne P., Daneman D., Delovitch T.L. Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J.Exp. Med. 172: 789, 1990.

    Article  PubMed  CAS  Google Scholar 

  25. Christie M.R., Hollands J.A., Brown T.J., Michelsen B.K., Delovitch T.L. Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase. J. Clin. Invest. 22: 240, 1993.

    Article  Google Scholar 

  26. Aguilar-Diosdado M., Parkinson D., Corbett J.A., et al. Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes 43(3): 418, 1994.

    PubMed  CAS  Google Scholar 

  27. Velloso L.A., Kampe O., Hallberg A., Christmanson L., Betsholtz C., Karlsson F.A. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type I diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J. Clin. Invest. 91: 2084, 1993.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  28. Rowley M.J., Mackay I.R., Chen Q., Knowles W.J., Zimmet P.Z. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41: 548, 1992.

    Article  PubMed  CAS  Google Scholar 

  29. Ujihara N., Daw K., Gianani R., Yu L., Powers A.C. ICA sera: differences in GAD reactivity and identification of a GAD protein epitope. Diabetes 42: 113A, 1993.

    Article  Google Scholar 

  30. Harrison L.C., Honeyman M.C., De Aizpurua H.J., et al. Inverse relationship between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365, 1993.

    Article  PubMed  CAS  Google Scholar 

  31. Linsong L., Hagopian W., Brashear H.R., Daniels T., Lernmark A. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J. Immunol. 152: 930, 1994.

    Google Scholar 

  32. Bjork E., Velloso L.A., Kampe O., Karlsson F.A. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 43: 161, 1994.

    Article  PubMed  CAS  Google Scholar 

  33. Martino G.V., Tappaz M.L., Braghi S., et al. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies. J. Autoimmunity 4(6): 915, 1991.

    Article  CAS  Google Scholar 

  34. Butler M.H., Solimena M., Dirkx R., Hayday A., De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 178: 2097, 1993.

    Article  PubMed  CAS  Google Scholar 

  35. Pietropaolo M., Castano L., Babu S., Powers A., Eisenbarth G.S. Islet cell autoantigen 69kd (ICA69): molecular cloning and characterization of a novel diabetes associated autoantigen. J. Clin. Invest. 92: 359, 1993.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  36. Karjalainen J., Martin J.M., Knip M., et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N.Engl.J. Med. 327: 302, 1992.

    Article  PubMed  CAS  Google Scholar 

  37. Karjalainen J., Saukkonen T., Savilahti E., Dosch H.-M. Disease-associated anti-bovine serum albumin antibodies in type I (insulin-dependent) diabetes mellitus are detected by particle concentration fluoroimmunoassay, and not by enzyme linked immunoassay. Diabetologia 35: 985, 1992.

    Article  PubMed  CAS  Google Scholar 

  38. Martin J.M., Trink B., Daneman D., Dosch H., Robinson B. Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM). Ann. Med. 23: 447, 1991.

    Article  PubMed  CAS  Google Scholar 

  39. Borch-Johnson K., Joner G., Mandrup-Poulsen T., et al. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. Lancet 2: 1083, 1984.

    Article  Google Scholar 

  40. Kostraba J.N., Cruickshanks K.J., Lawler-Heavner J., et al. Early exposure to cow’s milk and solid foods in infancy, genetic predisposition and risk of IDDM. Diabetes 42: 288, 1993.

    Article  PubMed  CAS  Google Scholar 

  41. Gerstein H.C. Cow’s milk exposure and type I diabetes mellitus — a critical overview of the clinical literature. Diabetes Care 17: 13, 1994.

    Article  PubMed  CAS  Google Scholar 

  42. Rabin D.U., Pleasic S.M., Palmer-Crocker R., Shapiro J.A. Cloning and expression of IDDM-specific human autoantigens. Diabetes 41: 183, 1992.

    Article  PubMed  CAS  Google Scholar 

  43. Karounos D.G., Wolinsky J.S., Thomas J.W. Monoclonal antibody to rubella virus capsid protein recognizes a B-cell antigen. J. Immunol. 150: 3080, 1993.

    PubMed  CAS  Google Scholar 

  44. Roep B.O., Kallan A.A., Hazenbos W.L.W., et al. T-cell reactivity to 38kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes Lancet 337: 1439, 1991.

  45. Honeyman M.C., Cram D.S., Harrison L.C. Transcription factor jun-B is target of autoreactive T-cells in IDDM. Diabetes 42: 626, 1993.

    Article  PubMed  CAS  Google Scholar 

  46. Thomas N.M., Ginsberg-Fellner F., Mcevoy R.C. Strong association between diabetes and displacement of mouse anti-rat insulinoma cell monoclonal antibody by human serum in vitro. Diabetes 39: 1203, 1990.

    Article  PubMed  CAS  Google Scholar 

  47. Christie M.R., Richard Y.M., Tun R.Y.M., et al. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM: Studies with identical twins. Diabetes 41: 782, 1992.

    Article  PubMed  CAS  Google Scholar 

  48. Bingley P.J., Christie M.R., Bonfanti R. Combined analysis of autoantibodies enhances prediction of IDDM in islet cell antibody (ICA) positive relatives. 12th International Immunology & Diabetes Workshop 1993; 1: 76. (abstract)

    Google Scholar 

  49. Dotta F., Gianani R., Dionisi S., Tiberti C., Eisenbarth G.S., DiMario U. Expression of anti-GM2-1 islet ganglioside antibodies in ICA+ relatives of type I diabetics. Autoimmunity 15(suppl): 70, 1993.

    Google Scholar 

  50. Castano L., Russo E., Zhou L., Lipes M.A., Eisenbarth G.S. Identification and cloning of a granule autoantigen (carboxypeptidase H) associated with type I diabetes. J. Clin. Endocrinol. Metab. 73: 1197, 1991.

    Article  PubMed  CAS  Google Scholar 

  51. Bleich D., Jackson R.A., Soeldner J.S., Eisenbarth G.S. Analysis of metabolic progression to Type I diabetes in islet cell antibody positive relatives of patients with Type I diabetes. Diabetes Care 13: 111, 1990.

    Article  PubMed  CAS  Google Scholar 

  52. Vardi P., Crisa L., Jackson R.A., et al. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type I (insulin-dependent) diabetic patients. Diabetologia 34: 93, 1991.

    Article  PubMed  CAS  Google Scholar 

  53. Jackson R.A., Vardi P., Herskowitz R.D., Soeldner J.S., Eisenbarth G.S. Dual parameter linear model for prediction of onset of type I diabetes in islet cell antibody positive relatives. Clin. Res. 36: 585A, 1988.

    Google Scholar 

  54. Mori Y., Suko M., Okudaira H., et al. Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia 29: 244, 1986.

    Article  PubMed  CAS  Google Scholar 

  55. Laupacis A., Gardell C., Dupre J., et al. Cyclosporin prevents diabetes mellitus in the BioBreeding/Worcester rat. Lancet i: 10, 1983.

    Article  Google Scholar 

  56. Like A.A. Insulin injections prevent diabetes (DB) in BioBreeding/Worcester (BB/W) rats. Diabetes 136: 3254, 1986.

    CAS  Google Scholar 

  57. Atkinson M., Maclaren N., Luchetta R., Burr I. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933, 1990.

    Article  PubMed  CAS  Google Scholar 

  58. Zhang J.Z., Davidson L., Eisenbarth G.S., Weiner H.L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88: 10252, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  59. Tisch R., Yang X.-D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72, 1993.

    Article  PubMed  CAS  Google Scholar 

  60. Feutren G., Assan G., Karsenty G., et al. Cyclosporine increases the rate and length of remissions in insulin dependent diabetes of recent onset. Results of a multicenter trial. Lancet 2: 119, 1986.

    CAS  Google Scholar 

  61. Martin S., Schernthaner G., Nerup J. Follow-up of cyclosporin A in Type I (insulin dependent) diabetes mellitus: lack of long term effects. Diabetologia 34: 429, 1991.

    Article  PubMed  CAS  Google Scholar 

  62. Shah S.C., Malone J.I., Simpson N.E. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N. Engl. J. Med. 320: 550, 1989.

    Article  PubMed  CAS  Google Scholar 

  63. Naquet P., Ellis J., Tibensky D., et al. T Cell Autoreactivity to Insulin in Diabetic and Related Non-Diabetic Individuals. J. Immunol. 140: 2569, 1988.

    PubMed  CAS  Google Scholar 

  64. Appel M.C., Dotta F., O’Neill J., Eisenbarth G.S. Beta cell activity regulates the expression of islet antigen determinant. Diabetologia 32: 461A, 1989.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gianani, R., Eisenbarth, G.S. Prediction and prevention of type I diabetes. J Endocrinol Invest 17, 533–543 (1994). https://doi.org/10.1007/BF03347747

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347747

Keywords

Navigation